Skip to main content

Company Name

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for TEVA-RISPERIDONE

Brand name

TEVA-RISPERIDONE

Company Name

TEVA CANADA LIMITED

Drug Identification Number

02264234

Ingredients & Strength

RISPERIDONE (4 MG)

Anatomical Therapeutical Chemical (ATC) Code

N05AX

Anatomical Therapeutical Chemical (ATC) Descriptor

ANTIPSYCHOTICS

Status

Shortage reports
Brand name	Packaging size	Status	Date Created	Date Updated	Reports
TEVA-RISPERIDONE	100	Resolved	2020-03-06	2020-04-02	107981
TEVA-RISPERIDONE	100	Resolved	2021-05-20	2021-07-09	139746
TEVA-RISPERIDONE	100	Resolved	2022-12-01	2022-12-22	176782
TEVA-RISPERIDONE	100	Actual shortage	2026-02-05	2026-02-05	277384

1

Showing 1 to 4 of 4

Discontinuation reports
Brand name	Packaging size	Status	Date Created	Date Updated	Reports
TEVA-RISPERIDONE	100	Reversed	2025-05-28	2025-06-04	258688

1

Showing 1 to 1 of 1

Company Name

Reports for TEVA-RISPERIDONE

Brand name TEVA-RISPERIDONE

Brand name

TEVA-RISPERIDONE